ArticleClinical cancer research : an official journal of the American Association for Cancer Research2007

Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract.

Addanki P Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.